The Replacement of Human Insulin with Insulin Analogs Patrick VexiauBernard BauduceauMarc Lévy Original Research Article 30 August 2012 Pages: 395 - 400
Is There a Rationale for Insulin Therapy in Pre-Diabetic Individuals? Sherwyn Schwartz Review Article 30 August 2012 Pages: 385 - 393
Optimizing the Benefits of Bisphosphonates in Osteoporosis Steven BoonenRoger BouillonDirk Vanderschueren Review Article 30 August 2012 Pages: 375 - 383
Is Bio-Identical Hormone Replacement Therapy Safer than Traditional Hormone Replacement Therapy? Jessica J. CurcioDebra A. WollnerLinda S. Kim Review Article 30 August 2012 Pages: 367 - 374
A Review of Transdermal Hormonal Contraception Alessandra Graziottin Review Article 30 August 2012 Pages: 359 - 365
Anabolic Agents for Osteoporosis Monica GirotraMishaela RJohn P Current Opinion 30 August 2012 Pages: 347 - 358
Neonatal Thyroxine Supplementation for Transient Hypothyroxinemia of Prematurity Edmund F. La GammaAleid G. van WassenaerDelbert Fisher Current Opinion 30 August 2012 Pages: 335 - 346
Spotlight on Inhaled Human Insulin (Exubera®) in Diabetes Mellitus Christopher DunnMonique P. Curran Apis Spotlight 17 September 2012 Pages: 329 - 331
Oral Paricalcitol James B. WetmoreL. Darryl Quarles Adis Drug Profile 17 September 2012 Pages: 326 - 326
Oral Paricalcitol Emma D. DeeksKatherine A. Lyseng-Williamson Apis Drug Profile 17 September 2012 Pages: 319 - 325
Metabolic Bone Disease in Children Elzbieta Skowrońska-JóźwiakRoman S. Lorenc Review Article 17 September 2012 Pages: 297 - 318
Gonadotropin-Releasing Hormone Analog Therapy for Central Precocious Puberty and Other Childhood Disorders Affecting Growth and Puberty Peter A. LeeChristopher P. Houk Review Article 17 September 2012 Pages: 287 - 296
The Effectiveness of Intensive Glycemic Control for the Prevention of Vascular Complications in Diabetes Mellitus Abu R. VasudevanAlassia BurnsVivian A. Fonseca Review Article 17 September 2012 Pages: 273 - 286
Opinion and Evidence for Treatments in Endocrine Disorders From the World Literature 30 August 2012 Pages: 257 - 263
User Experience with an Oral Contraceptive Containing Ethinylestradiol 30μg and Drospirenone 3mg (Yasmin®) in Clinical Practice Beate Schultz-ZehdenEwald Boschitsch Original Research Article 30 August 2012 Pages: 251 - 256
Impaired Quality of Life in Hypopituitary Adults with Growth Hormone Deficiency Jan Berend DeijenLucia I. Arwert Review Article 30 August 2012 Pages: 243 - 250
Osteogenesis Imperfecta Jean-Pierre DevogelaerChristine Coppin Review Article 30 August 2012 Pages: 229 - 242
Somatropin Therapy for Children with Prader- Willi Syndrome Ann C. Lindgren Therapy In Practice 30 August 2012 Pages: 223 - 228
The Role of Glycosaminoglycans and Sulodexide in the Treatment of Diabetic Nephropathy Cataldo AbaterussoGiovanni Gambaro Leading Article 30 August 2012 Pages: 211 - 222
The Treatment of Type 2 Diabetes Mellitus in Youth Jennifer L. MillerJanet H. Silverstein Leading Article 30 August 2012 Pages: 201 - 210
Opinion and Evidence for Treatments in Endocrine Disorders From the World Literature 30 August 2012 Pages: 193 - 199
Spotlight on Pioglitazone in Type 2 Diabetes Mellitus John WaughGillian M. KeatingDean M. Robinson Adis Spotlight 30 August 2012 Pages: 189 - 191
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome Karen E. Elkind-Hirsch Review Article 30 August 2012 Pages: 171 - 187
Somatropin Therapy and Cognitive Function in Adults with Growth Hormone Deficiency P. Sylze van Dam Review Article 30 August 2012 Pages: 159 - 170
Progress in Islet Transplantation in Patients with Type 1 Diabetes Mellitus Wayne TruongA. M. James Shapiro Leading Article 30 August 2012 Pages: 147 - 158
Prospects for the Development of Long-Acting Formulations of Human Somatropin Andreas JostelStephen M. Shalet Leading Article 30 August 2012 Pages: 139 - 145
The Case for Combination Therapy as First-Line Treatment for the Type 2 Diabetic Patient David S. H. Bell Current Opinion 30 August 2012 Pages: 131 - 137
Opinion and Evidence for Treatments in Endocrine Disorders From the World Literature 30 August 2012 Pages: 123 - 129
A Comparison of the Cycle Control, Safety, and Efficacy Profile of a 21-Day Regimen of Ethinylestradiol 20μg and Drospirenone 3mg with a 21-Day Regimen of Ethinylestradiol 20μg and Desogestrel 150μg Doris M. GruberJohannes C. HuberJoachim Marr Original Research Article 30 August 2012 Pages: 115 - 121
A Review of Non-Hormonal Options for the Relief of Menopausal Symptoms Paola Albertazzi Review Article 30 August 2012 Pages: 101 - 113
Dual Peroxisome Proliferator-Activated Receptor-α/γ Agonists Harrihar A. Pershadsingh Leading Article 30 August 2012 Pages: 89 - 99
Serotonergic Agents as an Alternative to Hormonal Therapy for the Treatment of Menopausal Vasomotor Symptoms Vered Stearns Leading Article 30 August 2012 Pages: 83 - 87
Does Treating Subclinical Hypothyroidism Improve Markers of Cardiovascular Risk? Fabio MonzaniAngela DardanoNadia Caraccio Current Opinion 30 August 2012 Pages: 65 - 81
Opinion and Evidence for Treatments in Endocrine Disorders From the World Literature 30 August 2012 Pages: 59 - 63
The Implantable Gastric Stimulator for Obesity Karl MillerElizabeth HoellerFranz Aigner Original Research Article 30 August 2012 Pages: 53 - 58
Effects of Transdermal Estrogen Replacement Therapy on Cardiovascular Risk Factors Dileep V. MenonWanpen Vongpatanasin Review Article 30 August 2012 Pages: 37 - 51
The Treatment of Severe Postmenopausal Osteoporosis Jean-Yves ReginsterNathalie Sarlet Review Article 30 August 2012 Pages: 15 - 23
The Role of Melanocyte- Stimulating Hormone in Insulin Resistance and Type 2 Diabetes Mellitus Jessica Lynn CostaUte HochgeschwenderMiles Brennan Leading Article 30 August 2012 Pages: 7 - 13
Prenatal Treatment of Congenital Adrenal Hyperplasia Ieuan Hughes Current Opinion 30 August 2012 Pages: 1 - 6
Opinion and Evidence for Treatments in Endocrine Disorders From the World Literature 30 August 2012 Pages: 391 - 397
Alendronate/Colecalciferol Michael KleerekoperAysegul Atmaca Adis Drug Profile 30 August 2012 Pages: 379 - 379
Alendronate/Colecalciferol Neil A. ReynoldsMonique P. Curran Adis Drug Profile 30 August 2012 Pages: 371 - 377